BEN ALI MECHAAL, Professor
Nabeul, Mrazga, 8000, Tunisia
Location status: Recruiting
NCT Number: NCT06740994
Former clinical studies have reported the superiority of the landmark guided paramedian approach above the classical landmark guided midline approach for the continuous spinal anesthesia especially in the elderly. On the other hand, more recent clinical trials have suggested that the use of ultrasound to guide spinal anesthesia will be safer and more effective than the conventional palpation-guided technique.
The aim of this study will be to compare the conventional "blind" landmark paramedian approach to the ultrasound "modern" guided midline approach for the continuous spinal anesthesia in the elderly with hip fractures.
Patients will randomly divided into two groups:
Group(PML): will undergo conventional landmark guided paramedian continuous spinal anesthesia Group (MUS): will undergo ultrasound guided midline continuous spinal anesthesia
Interested in participating?
Request Info65 year and older
All sexes
Interventional
Not applicable
All elderly patients above 65 years old scheduled for elective surgery for hip fracture under continuous spinal anesthesia will be included in the study.
Patients will randomly divided into two groups by using random number generating software (Research Randomizer Version 4.0) Group(PML): will undergo conventional landmark guided paramedian continuous spinal anesthesia Group(MUS) : will undergo ultrasound guided midline continuous spinal anesthesia A written informed consent will be obtained from all participants, who will be blinded as to their allocated group.
After establishing a baseline monitoring (3 lead ECG, pulse oximetry and non-invasive blood pressure) and an intravenous access, a fascia-iliaca ultrasound guided block at the fractured hip will be performed for all patients by the injection of 20 ml of 1.5 % lidocaine.
15 minutes later with the aid of an assistant, the patient will be positioned at the edge of the operating table in an arched back posture.
In both groups the continuous spinal anesthesia(CSA) will be performed with one of three anesthesiologists (two residents in their fourth year of training anesthesia and one associate professor), each have sufficient experience in performing neuraxial ultrasound scans prior to the study. To fulfill this they will use an 18 gauge Tuohy needle with a 22 gauge intrathecal catheter.
In group PML:
The anesthesiologist will star by drawing the 10th rib line then he will by palpation identify the most prominent spinous process beneath. At this level he will mark on the patient skin the point of injection which will be1 cm lateral and 1 cm caudal to the caudal edge of the spinous process chosen.
After infiltration of the skin with 3 ml of 1% lidocaine at the marked site, the anesthesiologist will introduce the tuohy needle in a cephalomedial direction 10 to 15° off the sagittal plane.
when cerebrospinal fluid will be obtained, the CSA (continuous spinal anesthesia) catheter will be advanced 3 cm cephalad to the intrathecal space and taped to the skin.
The patient will be then returned to dorsal position and a volume of 30 ug of fentanyl and 3 ml of 0.1% isobar bupivacaine will be injected intrathecally via the catheter.
The intervertebral level at which the injection will be done,will be scanned with ultrasound at the end of the surgery, before CSA catheter withdrawal.
In group MUS:
The anesthesiologist will use a portable ultrasonography with a curved 2-5 MHz (Mega Hertz) probe to detect the sacrum in the paramedian sagittal oblique view (PSO) of the neuroaxis.
Than the transducer will be moved cephalad to scan the quality of interspinous spaces from L5/S1 to L2/L3. The interlaminar space that will have the best PSO quality i.e the clearest and largest ultrasound image of the posterior complex ( ligamentum flavum and posterior dura) and anterior complex ( posterior longitudinal ligament and anterior dura) will be chosen as the interspace for injection.
At this level a skin marker will be used to mark the midpoint of the short borders of the probe. Following this the probe will be rotated by 90° to obtain the transverse median view (TM) and by the same way the midpoint of the short borders of the probe will be marked.
The intersection of these two marks will be used as the point of injection. Similarly skin will be infiltrated with lidocaine and the tuohy needle will be inserted in the cephalomedial plane with a cephalad angle estimated by the probe inclination in the TM view.In this group, the anesthesiologist will not palpate the landmarks except he changing technique.For the rest of the procedure, the same steps will be followed.
In both groups, an alternative technique would be used if unsuccessful after 3 attempts( landmark/ultrasound guided paramedian approach for MUS Group ; landmark/ultrasound midline approach for PML Group).
For all participants strict asepsis will be respected throughout all the procedure, The distance needed to reach the intrathecal space from the skin will be recorded and the quality of the interspinous spaces chosen will be noted in the PSO and TM ultrasound views using a predefined scale (good = both posterior and anterior complex visible ; intermediate = posterior or anterior complex visible ; poor = neither complex visible)
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
a blind landmark scanning will be done and skin marking of the best palpable spinous process will be made.
the site of injection will be determined by palpation. continuous spinal anesthesia will be performed via paramedian approach.
Other names: PML
a preprocedural ultrasound scanning will be done, and skin marking of the best quality space will be made.
the site of injection and the insertion angle of the needle will be determined by ultrasound.
continuous spinal anesthesia will be performed via midline approach.
Other names: MUS
Time frame: from the first insertion of the needle until the fixation of the continuous spinal anesthesia catheter to patient skin
the number of forward advancements of the Tuohy needle in a given interspinous space (i.e withdrawal and redirection of Tuohy needle without exiting the skin)
Time frame: from the first insertion of the needle until the fixation of the continuous spinal anesthesia catheter to patient skin
the number of times the tuohy needle was withdrawn from the skin and reinserted
Time frame: from the first insertion of the needle until the fixation of the continuous spinal anesthesia catheter to patient skin
a single needle insertion with no redirection
Time frame: time taken from start of palpating or ultrasound scanning to the marking of the needle entry point
in group PML: time from which the anesthesiologist started palpating to identify the landmarks to the needle entry point marking in group MUS: time from which the ultrasound probe was placed on the skin to the needle entry point marking
Time frame: time taken from the start of the first insertion of the needle to the completion of fixation of the catheter to patient skin
time from first needle insertion to fixation of continuous spinal anesthesia catheter to patient skin
Time frame: from the star of first needle insertion to the completion of the continuous spinal anesthesia
defined as: incidence of radicular pain, parasthesia and blood in the Tuohy needle
Time frame: from the start of identifying landmarks until the patient leaves the operation room
the interspinous level at which dural puncture was done
Contact information is provided by the study sponsor or research team.
University Tunis El Manar
Other
Ultrasound Guided Midline Continuous Spinal Anesthesia in the Elderly : is There an Advantage Over Conventional Landmark Paramedian Technique: a Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07450014
Anxiety, Anxiety Disorders
Sanliurfa, Turkey (Türkiye)
View Trial DetailsNCT07499947
Cardiovascular Diseases, Cesarean Section
Kayseri, Turkey (Türkiye)
View Trial DetailsNCT07500519
Cardiovascular Diseases, Hypotension
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT07481851
Aged, Cardiovascular Diseases
Ankara, Yenimahalle, Turkey (Türkiye)
View Trial Details